A second stem cell patentability case is referred to the CJEU
In International Stem Cell Corporation (ISCC) v Comptroller General of Patents, Henry Carr QC, sitting as a deputy High Court judge in the Patents Court, has made only the second reference to the Court of Justice of the European Union (CJEU) for a preliminary ruling on the patentability of stem cells, under Directive 98/44/ED (the Biotechnology Directive). The question referred concerns whether stem cells obtained from parthenogenically stimulated human ova are excluded from patentability as ‘human embryos’ under that directive.
ISCC’s method of obtaining stem cells does not involve the destruction of a fertilised ovum and the cells obtained (pluripotent cells) are claimed not to be capable of developing into a human being. Therefore, this technology, for which ISCC seeks two patents, is seen as a more morally acceptable alternative to obtaining stem cells directly from human embryos, or cell lines deriving from them. The latter technology is destructive of the embryo and produces cells that can potentially develop into a human being (totipotent cells). Inventions of this type were ruled unpatentable by the CJEU in its Brüstle decision last year…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
For the tax year from 6 April 2014, the standard lifetime allowance has reduced from £1.5m to £1.25m.
One of the areas highlighted last year by the Regulator was the regulation of workplace DC pension schemes.
Analysis from The Lawyer
As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014.
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world